Get more information on Stem Cell Therapy Market - Request Sample Report
The Stem Cell Therapy Market Size was valued at USD 287 million in 2023 and is witnessed to reach USD 1,113.12 million by 2032 and grow at a CAGR of 17.10% over the forecast period 2024-2032. The lifted burden of chronic diseases has resulted in the advancement of regenerative stem cell therapy which is being investigated as a good therapeutic agent for these fatal disorders. As an illustration, in December 2023 Mayo Clinic researchers and international collaborators showed that the propagation of stem cell-based regenerative therapy was effective for advanced heart failure.
In the January 2023 postponement period, UC Davis Health researchers showed that a stem cell therapy for treating Crohn's disease in preclinical trials fared well. Therefore, the augmented research undertaking in stem cell therapy is expected to drive industry expansion during the forecast years.
Additionally, burgeoning funding/grants to design prospective stem cell-based therapeutics are further anticipated to uphold the market growth. To strengthen its work towards the creation of cutting-edge stem cell treatments to treat several deadly illnesses, CellVoyant supported GBP 7.6 million (USD9.49 million) from Octopus Ventures in January 2024 as an illustration Likewise, in February 2023 the National Institutes of Health awarded USD 2.5 million to a group at Purdue University for stem cell research on which they are working with allogeneic ISCTCs into phase III testing. Therefore, such cash flow activities are expected to fuel the growth of the industry.
Moreover, some other strategic initiatives are anticipated to boost the growth in the world market of pipe and joint systems. In April 2023 for example; the USFDA approved Omisirge by Gamida Cell Ltd an innovative leader in cellular therapy for pediatric and adult patients with hematological malignancies. Approval of this nature is likely to expand patient access and drive optimum clinical outcomes within the stem cell transplant setting. Thus, this is likely to support market growth over the next few years.
MARKET DYNAMICS:
KEY DRIVERS:
Increasing Prevalence of Chronic Disorders is responsible for the Increasing Demand for Stem Cell Therapy Solutions.
The Growing Demand for Stem Cell Banking is Boosting the Market Growth.
RESTRAINTS:
Stringent Regulatory Scenario is Hindering Stem Cell Therapy Market Growth.
The Higher Costs of Stem Cell Therapy Procedures Can Limit the Adoption of Stem Cell Therapy.
OPPORTUNITY:
Technological Advancements are Offering a Lucrative Growth Opportunity for Stem Cell Therapy Procedures.
Hefty R&D Investments are Responsible for the Market Growth During Upcoming Years.
By Product
Adult Stem Cells held a market share of 76.36% by the year 2023 as this is done without destruction while Embryonic stem cells are destroyed adult stem cells do not carry the threat of graft rejection. Increasing cell banking services along with the development in biopreservation and cryopreservation are expected to drive adult stem cell demand. Adult cells suffer from fewer ethical concerns, further driving the market for this segment. Autologous transformation, low risk of tumor formation, and established treatment options are the several benefits in the US that can be achieved through the adult stem cell banking segment in next forthcoming years.
By Application
An increase in the incidence of cancer and malignancies is expected to drive segmental growth; responsible for 32% market share by 2023. Cancer Australia, for example, states up to 4,600 people will be diagnosed with kidney cancer this year compared to 4,552 in the last calendar period. Kidney cancer is ranked the seventh most common cause of diagnosis in Australia with around 1 in every 65 Australians being afflicted. The increasing prevalence of cancer is expected to further boost the demand for cell therapies such as stem cell therapy to treat it efficiently.
Moreover, in the past few years stem cells have been useful for the repopulation of blood and also immuno-reconstitution following cancer treatment. Moreover, these cells have gained immense popularity among the scientific fraternity as a modality for anti-tumor agent delivery and their utility in tissue regeneration. Quite a few bodies have after implementation also praised this tumor-treating mode. As of data from the Da Vinci Wellness Center (DVC Stem) in October 2023, stem cells have a notable success rate for cancer where around 87.5% experienced improvements.
By Therapy
In terms of revenue generation, the Allogenic therapy segment held for 60% share of this market in 2023. The growth in this segment can be attributed to factors such as the high cost of treatment and increasing stem cell banking. In addition, a lot of cell therapy companies are waiving their business from autologous and moving on to allogenic. As a consequence, this segment is anticipated to push up the growth of the equivalent market.
Further, the competitive moves by major market players to enhance their product offerings will also provide significant prospects over the forecast period. For example, Acepodia raised USD 47M in Series B financing for its allogenic cell therapy candidates’ pipeline just this March of 2021. Later, in June 2022, Immatics had done partnership for developing gamma delta allogeneic cell therapy programs while extending its collaboration with the pharmaceutical firm Bristol Myers Squibb.
REGIONAL ANALYSIS:
In North America, the market accounted for 44% of the market share owing to the higher incidence rates combined with rising research in stem cell therapies, increased adoption of regenerative medicine within the region, and supportive regulatory framework.
The rise in the incidence of cancer cases in the US will drive market growth. In the same way, based on this data more people will have mouth cancer in 2024 as per the American Cancer Society which was around to report about 15,490 such cases compared with that of the previous year when it reported only --14,820. This is anticipated to propel the demand for stem cell therapies globally as a portion of these therapies are used in advanced cancer treatments, thus subsequently driving the growth of the stem cell therapy market during the projected timeframe.
An increasing focus on the potential of stem cells in cancer management has spurred researchers to explore cell-mediated therapies for various types of cancers. Stem cell therapies in cancer were highlighted by Cedars-Sinai scientists earlier this year, showing how they increase the effectiveness of standard treatments (January 2022).
Likewise, in December 2022 City of Hope and its Alpha Stem Cell Clinic received an $8 million grant from the California Institute of Regenerative Medicine for its work with regenerative medicine and cancer. Therefore, any increase in these research efforts is likely to support the growth of regional stem cell therapy markets.
Do You Need any Customization Research on Stem Cell Therapy Market - Enquire Now
KEY PLAYERS:
The key market players include Thermo Fisher Scientific, Inc., Lonza, Merck KGaA, CellGenix GmbH, Takara Bio, Cellartis AB, AcceGen, Cell Applications, Inc., ATCC, PromoCell GmbH, Bio-Techne, STEMCELL Technologies Inc. & other players.
RECENT DEVELOPMENTS
In December 2023, The University of Texas at San Antonio (UTSA) and BioBridge Global subsidiary GenCure signed a master services agreement that formalized their partnership. The agreement details their collaborations to drive the cell therapy product and service development process.
In September 2023, The SKAN Research Trust shared its operations with Wellcome-MRC Cambridge Stem Cell Institute hosted in September. They saw a joint research program into the genomic architecture of age-related neurodegeneration diseases in an Indian population.
Stem Cell Therapy Market Report Scope:
| Report Attributes | Details |
| Market Size in 2023 | US$ 287 Million |
| Market Size by 2032 | US$ 1,113.12 Million |
| CAGR | CAGR of 17.10% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | •By Product (Adult Stem Cells (ASCs), Human Embryonic Stem Cells (HESCs), Induced Pluripotent Stem Cells (iPSCs) & Very Small Embryonic Like Stem Cells) •By Application (Neurological Disorders, Orthopaedic Treatments, Oncology Disorders, Injuries and Wounds, Cardiovascular Disorders & Others) •By Therapy (Allogeneic, Autologic & Syngeneic) •By End-Use (Pharmaceutical & Biotechnology Companies, Hospitals & Cell Banks & Academic & Research Institutes) •By Technology (Cell Acquisition, Cell Production, Cryopreservation & Expansion and Sub-Culture) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Thermo Fisher Scientific, Inc., Lonza, Merck KGaA, CellGenix GmbH, Takara Bio, Cellartis AB, AcceGen, Cell Applications, Inc., ATCC, PromoCell GmbH, Bio-Techne, STEMCELL Technologies Inc. & other players |
| Key Drivers | •Increasing Prevalence of Chronic Disorders is responsible for the Increasing Demand for Stem Cell Therapy Solutions. •The Growing Demand for Stem Cell Banking is Boosting the Market Growth. |
| RESTRAINTS | •Stringent Regulatory Scenario is Hindering Stem Cell Therapy Market Growth. •The Higher Costs of Stem Cell Therapy Procedures Can Limit the Adoption of Stem Cell Therapy. |
Ans: The U.S. led the Stem Cell Therapy in the North American region with the highest revenue share in 2023.
Ans: Factors such as stringent regulatory scenarios & the higher costs of stem cell therapy procedures can limit the adoption of stem cell therapy. can restrict the growth of the stem cell therapy market.
Ans: Mesenchymal Stem Cells (MSCs) will grow rapidly in the Stem Cell Therapy Market from 2024-2032.
Ans: The expected CAGR of the Global Stem Cell Therapy Market during the forecast period is 17.10%.
Ans: The Stem Cell Therapy Market was valued at USD 287 million in 2023.
TABLE OF CONTENTS
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Industry Flowchart
3. Research Methodology
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
5. Porter’s 5 Forces Model
6. Pest Analysis
7. Stem Cell Therapy Market Segmentation, By Product
7.1 Introduction
7.2 Adult Stem Cells (ASCs)
7.3 Human Embryonic Stem Cells (HESCs)
7.4 Induced Pluripotent Stem Cells (iPSCs)
7.5 Very Small Embryonic Like Stem Cells
8. Stem Cell Therapy Market Segmentation, By Application
8.1 Introduction
8.2 Neurological Disorders
8.3 Orthopaedic Treatments
8.4 Oncology Disorders
8.5 Injuries and Wounds
8.6 Cardiovascular Disorders
8.7 Others
9. Stem Cell Therapy Market Segmentation, By Therapy
9.1 Introduction
9.2 Allogeneic
9.3 Autologic
9.4 Syngeneic
10. Stem Cell Therapy Market Segmentation, By End-Use
10.1 Introduction
10.2 Pharmaceutical & Biotechnology Companies
10.3 Hospitals & Cell Banks
10.4 Academic & Research Institutes
11. Stem Cell Therapy Market Segmentation, By Technology
11.1 Introduction
11.2 Cell Acquisition
11.3 Cell Production
11.4 Cryopreservation
11.5 Expansion And Sub-Culture
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 Trend Analysis
12.2.2 North America Stem Cell Therapy Market By Country
12.2.3 North America Stem Cell Therapy Market By Product
12.2.4 North America Stem Cell Therapy Market By Application
12.2.5 North America Stem Cell Therapy Market By Therapy
12.2.6 North America Stem Cell Therapy Market, By End-Use
12.2.7 North America Stem Cell Therapy Market, By Technology
12.2.8 USA
12.2.8.1 USA Stem Cell Therapy Market By Product
12.2.8.2 USA Stem Cell Therapy Market By Application
12.2.8.3 USA Stem Cell Therapy Market By Therapy
12.2.8.4 USA Stem Cell Therapy Market, By End-Use
12.2.8.5 USA Stem Cell Therapy Market, By Technology
12.2.9 Canada
12.2.9.1 Canada Stem Cell Therapy Market By Product
12.2.9.2 Canada Stem Cell Therapy Market By Application
12.2.9.3 Canada Stem Cell Therapy Market By Therapy
12.2.9.4 Canada Stem Cell Therapy Market, By End-Use
12.2.9.5 Canada Stem Cell Therapy Market, By Technology
12.2.10 Mexico
12.2.10.1 Mexico Stem Cell Therapy Market By Product
12.2.10.2 Mexico Stem Cell Therapy Market By Application
12.2.10.3 Mexico Stem Cell Therapy Market By Therapy
12.2.10.4 Mexico Stem Cell Therapy Market, By End-Use
12.2.10.5 Mexico Stem Cell Therapy Market, By Technology
12.3 Europe
12.3.1 Trend Analysis
12.3.2 Eastern Europe
12.3.2.1 Eastern Europe Stem Cell Therapy Market By Country
12.3.2.2 Eastern Europe Stem Cell Therapy Market By Product
12.3.2.3 Eastern Europe Stem Cell Therapy Market By Application
12.3.2.4 Eastern Europe Stem Cell Therapy Market By Therapy
12.3.2.5 Eastern Europe Stem Cell Therapy Market By End-Use
12.3.2.6 Eastern Europe Stem Cell Therapy Market, By Technology
12.3.2.7 Poland
12.3.2.7.1 Poland Stem Cell Therapy Market By Product
12.3.2.7.2 Poland Stem Cell Therapy Market By Application
12.3.2.7.3 Poland Stem Cell Therapy Market By Therapy
12.3.2.7.4 Poland Stem Cell Therapy Market By End-Use
12.3.2.7.5 Poland Stem Cell Therapy Market, By Technology
12.3.2.8 Romania
12.3.2.8.1 Romania Stem Cell Therapy Market By Product
12.3.2.8.2 Romania Stem Cell Therapy Market By Application
12.3.2.8.3 Romania Stem Cell Therapy Market By Therapy
12.3.2.8.4 Romania Stem Cell Therapy Market By End-Use
12.3.2.8.5 Romania Stem Cell Therapy Market, By Technology
12.3.2.9 Hungary
12.3.2.9.1 Hungary Stem Cell Therapy Market By Product
12.3.2.9.2 Hungary Stem Cell Therapy Market By Application
12.3.2.9.3 Hungary Stem Cell Therapy Market By Therapy
12.3.2.9.4 Hungary Stem Cell Therapy Market By End-Use
12.3.2.9.5 Hungary Stem Cell Therapy Market, By Technology
12.3.2.10 Turkey
12.3.2.10.1 Turkey Stem Cell Therapy Market By Product
12.3.2.10.2 Turkey Stem Cell Therapy Market By Application
12.3.2.10.3 Turkey Stem Cell Therapy Market By Therapy
12.3.2.10.4 Turkey Stem Cell Therapy Market By End-Use
12.3.2.10.5 Turkey Stem Cell Therapy Market, By Technology
12.3.2.11 Rest of Eastern Europe
12.3.2.11.1 Rest of Eastern Europe Stem Cell Therapy Market By Product
12.3.2.11.2 Rest of Eastern Europe Stem Cell Therapy Market By Application
12.3.2.11.3 Rest of Eastern Europe Stem Cell Therapy Market By Therapy
12.3.2.11.4 Rest of Eastern Europe Stem Cell Therapy Market By End-Use
12.3.2.11.5 Rest of Eastern Europe Stem Cell Therapy Market, By Technology
12.3.3 Western Europe
12.3.3.1 Western Europe Stem Cell Therapy Market By Country
12.3.3.2 Western Europe Stem Cell Therapy Market By Product
12.3.3.3 Western Europe Stem Cell Therapy Market By Application
12.3.3.4 Western Europe Stem Cell Therapy Market By Therapy
12.3.3.5 Western Europe Stem Cell Therapy Market By End-Use
12.3.3.6 Western Europe Stem Cell Therapy Market, By Technology
12.3.3.7 Germany
12.3.3.7.1 Germany Stem Cell Therapy Market By Product
12.3.3.7.2 Germany Stem Cell Therapy Market By Application
12.3.3.7.3 Germany Stem Cell Therapy Market By Therapy
12.3.3.7.4 Germany Stem Cell Therapy Market By End-Use
12.3.3.7.5 Germany Stem Cell Therapy Market, By Technology
12.3.3.8 France
12.3.3.8.1 France Stem Cell Therapy Market By Product
12.3.3.8.2 France Stem Cell Therapy Market By Application
12.3.3.8.3 France Stem Cell Therapy Market By Therapy
12.3.3.8.4 France Stem Cell Therapy Market By End-Use
12.3.3.8.5 France Stem Cell Therapy Market, By Technology
12.3.3.9 UK
12.3.3.9.1 UK Stem Cell Therapy Market By Product
12.3.3.9.2 UK Stem Cell Therapy Market By Application
12.3.3.9.3 UK Stem Cell Therapy Market By Therapy
12.3.3.9.4 UK Stem Cell Therapy Market By End-Use
12.3.3.9.5 UK Stem Cell Therapy Market, By Technology
12.3.3.10 Italy
12.3.3.10.1 Italy Stem Cell Therapy Market By Product
12.3.3.10.2 Italy Stem Cell Therapy Market By Application
12.3.3.10.3 Italy Stem Cell Therapy Market By Therapy
12.3.3.10.4 Italy Stem Cell Therapy Market By End-Use
12.3.3.10.5 Italy Stem Cell Therapy Market, By Technology
12.3.3.11 Spain
12.3.3.11.1 Spain Stem Cell Therapy Market By Product
12.3.3.11.2 Spain Stem Cell Therapy Market By Application
12.3.3.11.3 Spain Stem Cell Therapy Market By Therapy
12.3.3.11.4 Spain Stem Cell Therapy Market By End-Use
12.3.3.11.5 Spain Stem Cell Therapy Market, By Technology
12.3.3.12 Netherlands
12.3.3.12.1 Netherlands Stem Cell Therapy Market By Product
12.3.3.12.2 Netherlands Stem Cell Therapy Market By Application
12.3.3.12.3 Netherlands Stem Cell Therapy Market By Therapy
12.3.3.12.4 Netherlands Stem Cell Therapy Market By End-Use
12.3.3.12.5 Netherlands Stem Cell Therapy Market, By Technology
12.3.3.13 Switzerland
12.3.3.13.1 Switzerland Stem Cell Therapy Market By Product
12.3.3.13.2 Switzerland Stem Cell Therapy Market By Application
12.3.3.13.3 Switzerland Stem Cell Therapy Market By Therapy
12.3.3.13.4 Switzerland Stem Cell Therapy Market By End-Use
12.3.3.13.5 Switzerland Stem Cell Therapy Market, By Technology
12.3.3.14 Austria
12.3.3.14.1 Austria Stem Cell Therapy Market By Product
12.3.3.14.2 Austria Stem Cell Therapy Market By Application
12.3.3.14.3 Austria Stem Cell Therapy Market By Therapy
12.3.3.14.4 Austria Stem Cell Therapy Market By End-Use
12.3.3.14.5 Austria Stem Cell Therapy Market, By Technology
12.3.3.15 Rest of Western Europe
12.3.3.15.1 Rest of Western Europe Stem Cell Therapy Market By Product
12.3.3.15.2 Rest of Western Europe Stem Cell Therapy Market By Application
12.3.3.15.3 Rest of Western Europe Stem Cell Therapy Market By Therapy
12.3.3.15.4 Rest of Western Europe Stem Cell Therapy Market By End-Use
12.3.3.15.5 Rest of Western Europe Stem Cell Therapy Market, By Technology
12.4 Asia-Pacific
12.4.1 Trend Analysis
12.4.2 Asia-Pacific Stem Cell Therapy Market By Country
12.4.3 Asia-Pacific Stem Cell Therapy Market By Product
12.4.4 Asia-Pacific Stem Cell Therapy Market By Application
12.4.5 Asia-Pacific Stem Cell Therapy Market By Therapy
12.4.6 Asia-Pacific Stem Cell Therapy Market By End-Use
12.4.7 Asia-Pacific Stem Cell Therapy Market, By Technology
12.4.8 China
12.4.8.1 China Stem Cell Therapy Market By Product
12.4.8.2 China Stem Cell Therapy Market By Application
12.4.8.3 China Stem Cell Therapy Market By Therapy
12.4.8.4 China Stem Cell Therapy Market By End-Use
12.4.8.5 China Stem Cell Therapy Market, By Technology
12.4.9 India
12.4.9.1 India Stem Cell Therapy Market By Product
12.4.9.2 India Stem Cell Therapy Market By Application
12.4.9.3 India Stem Cell Therapy Market By Therapy
12.4.9.4 India Stem Cell Therapy Market By End-Use
12.4.9.5 India Stem Cell Therapy Market, By Technology
12.4.10 Japan
12.4.10.1 Japan Stem Cell Therapy Market By Product
12.4.10.2 Japan Stem Cell Therapy Market By Application
12.4.10.3 Japan Stem Cell Therapy Market By Therapy
12.4.10.4 Japan Stem Cell Therapy Market By End-Use
12.4.10.5 Japan Stem Cell Therapy Market, By Technology
12.4.11 South Korea
12.4.11.1 South Korea Stem Cell Therapy Market By Product
12.4.11.2 South Korea Stem Cell Therapy Market By Application
12.4.11.3 South Korea Stem Cell Therapy Market By Therapy
12.4.11.4 South Korea Stem Cell Therapy Market By End-Use
12.4.11.5 South Korea Stem Cell Therapy Market, By Technology
12.4.12 Vietnam
12.4.12.1 Vietnam Stem Cell Therapy Market By Product
12.4.12.2 Vietnam Stem Cell Therapy Market By Application
12.4.12.3 Vietnam Stem Cell Therapy Market By Therapy
12.4.12.4 Vietnam Stem Cell Therapy Market By End-Use
12.4.12.5 Vietnam Stem Cell Therapy Market, By Technology
12.4.13 Singapore
12.4.13.1 Singapore Stem Cell Therapy Market By Product
12.4.13.2 Singapore Stem Cell Therapy Market By Application
12.4.13.3 Singapore Stem Cell Therapy Market By Therapy
12.4.13.4 Singapore Stem Cell Therapy Market By End-Use
12.4.13.5 Singapore Stem Cell Therapy Market, By Technology
12.4.14 Australia
12.4.14.1 Australia Stem Cell Therapy Market By Product
12.4.14.2 Australia Stem Cell Therapy Market By Application
12.4.14.3 Australia Stem Cell Therapy Market By Therapy
12.4.14.4 Australia Stem Cell Therapy Market By End-Use
12.4.14.5 Australia Stem Cell Therapy Market, By Technology
12.4.15 Rest of Asia-Pacific
12.4.15.1 Rest of Asia-Pacific Stem Cell Therapy Market By Product
12.4.15.2 Rest of Asia-Pacific Stem Cell Therapy Market By Application
12.4.15.3 Rest of Asia-Pacific Stem Cell Therapy Market By Therapy
12.4.15.4 Rest of Asia-Pacific Stem Cell Therapy Market By End-Use
12.4.15.5 Rest of Asia-Pacific Stem Cell Therapy Market, By Technology
12.5 Middle East & Africa
12.5.1 Trend Analysis
12.5.2 Middle East
12.5.2.1 Middle East Stem Cell Therapy Market By Country
12.5.2.2 Middle East Stem Cell Therapy Market By Product
12.5.2.3 Middle East Stem Cell Therapy Market By Application
12.5.2.4 Middle East Stem Cell Therapy Market By Therapy
12.5.2.5 Middle East Stem Cell Therapy Market By End-Use
12.5.2.6 Middle East Stem Cell Therapy Market, By Technology
12.5.2.7 UAE
12.5.2.7.1 UAE Stem Cell Therapy Market By Product
12.5.2.7.2 UAE Stem Cell Therapy Market By Application
12.5.2.7.3 UAE Stem Cell Therapy Market By Therapy
12.5.2.7.4 UAE Stem Cell Therapy Market By End-Use
12.5.2.7.5 UAE Stem Cell Therapy Market, By Technology
12.5.2.8 Egypt
12.5.2.8.1 Egypt Stem Cell Therapy Market By Product
12.5.2.8.2 Egypt Stem Cell Therapy Market By Application
12.5.2.8.3 Egypt Stem Cell Therapy Market By Therapy
12.5.2.8.4 Egypt Stem Cell Therapy Market By End-Use
12.5.2.8.5 Egypt Stem Cell Therapy Market, By Technology
12.5.2.9 Saudi Arabia
12.5.2.9.1 Saudi Arabia Stem Cell Therapy Market By Product
12.5.2.9.2 Saudi Arabia Stem Cell Therapy Market By Application
12.5.2.9.3 Saudi Arabia Stem Cell Therapy Market By Therapy
12.5.2.9.4 Saudi Arabia Stem Cell Therapy Market By End-Use
12.5.2.9.5 Saudi Arabia Stem Cell Therapy Market, By Technology
12.5.2.10 Qatar
12.5.2.10.1 Qatar Stem Cell Therapy Market By Product
12.5.2.10.2 Qatar Stem Cell Therapy Market By Application
12.5.2.10.3 Qatar Stem Cell Therapy Market By Therapy
12.5.2.10.4 Qatar Stem Cell Therapy Market By End-Use
12.5.2.10.5 Qatar Stem Cell Therapy Market, By Technology
12.5.2.11 Rest of Middle East
12.5.2.11.1 Rest of Middle East Stem Cell Therapy Market By Product
12.5.2.11.2 Rest of Middle East Stem Cell Therapy Market By Application
12.5.2.11.3 Rest of Middle East Stem Cell Therapy Market By Therapy
12.5.2.11.4 Rest of Middle East Stem Cell Therapy Market By End-Use
12.5.2.11.5 Rest of Middle East Stem Cell Therapy Market, By Technology
12.5.3 Africa
12.5.3.1 Africa Stem Cell Therapy Market By Country
12.5.3.2 Africa Stem Cell Therapy Market By Product
12.5.3.3 Africa Stem Cell Therapy Market By Application
12.5.3.4 Africa Stem Cell Therapy Market By Therapy
12.5.3.5 Africa Stem Cell Therapy Market By End-Use
12.5.3.6 Africa Stem Cell Therapy Market, By Technology
12.5.3.7 Nigeria
12.5.3.7.1 Nigeria Stem Cell Therapy Market By Product
12.5.3.7.2 Nigeria Stem Cell Therapy Market By Application
12.5.3.7.3 Nigeria Stem Cell Therapy Market By Therapy
12.5.3.7.4 Nigeria Stem Cell Therapy Market By End-Use
12.5.3.7.5 Nigeria Stem Cell Therapy Market, By Technology
12.5.3.8 South Africa
12.5.3.8.1 South Africa Stem Cell Therapy Market By Product
12.5.3.8.2 South Africa Stem Cell Therapy Market By Application
12.5.3.8.3 South Africa Stem Cell Therapy Market By Therapy
12.5.3.8.4 South Africa Stem Cell Therapy Market By End-Use
12.5.3.8.5 South Africa Stem Cell Therapy Market, By Technology
12.5.3.9 Rest of Africa
12.5.3.9.1 Rest of Africa Stem Cell Therapy Market By Product
12.5.3.9.2 Rest of Africa Stem Cell Therapy Market By Application
12.5.3.9.3 Rest of Africa Stem Cell Therapy Market By Therapy
12.5.3.9.4 Rest of Africa Stem Cell Therapy Market By End-Use
12.5.3.9.5 Rest of Africa Stem Cell Therapy Market, By Technology
12.6 Latin America
12.6.1 Trend Analysis
12.6.2 Latin America Stem Cell Therapy Market By country
12.6.3 Latin America Stem Cell Therapy Market By Product
12.6.4 Latin America Stem Cell Therapy Market By Application
12.6.5 Latin America Stem Cell Therapy Market By Therapy
12.6.6 Latin America Stem Cell Therapy Market By End-Use
12.6.7 Latin America Stem Cell Therapy Market, By Technology
12.6.8 Brazil
12.6.8.1 Brazil Stem Cell Therapy Market By Product
12.6.8.2 Brazil Stem Cell Therapy Market By Application
12.6.8.3 Brazil Stem Cell Therapy Market By Therapy
12.6.8.4 Brazil Stem Cell Therapy Market By End-Use
12.6.8.5 Brazil Stem Cell Therapy Market, By Technology
12.6.9 Argentina
12.6.9.1 Argentina Stem Cell Therapy Market By Product
12.6.9.2 Argentina Stem Cell Therapy Market By Application
12.6.9.3 Argentina Stem Cell Therapy Market By Therapy
12.6.9.4 Argentina Stem Cell Therapy Market By End-Use
12.6.9.5 Argentina Stem Cell Therapy Market, By Technology
12.6.10 Colombia
12.6.10.1 Colombia Stem Cell Therapy Market By Product
12.6.10.2 Colombia Stem Cell Therapy Market By Application
12.6.10.3 Colombia Stem Cell Therapy Market By Therapy
12.6.10.4 Colombia Stem Cell Therapy Market By End-Use
12.6.10.5 Colombia Stem Cell Therapy Market, By Technology
12.6.11 Rest of Latin America
12.6.11.1 Rest of Latin America Stem Cell Therapy Market By Product
12.6.11.2 Rest of Latin America Stem Cell Therapy Market By Application
12.6.11.3 Rest of Latin America Stem Cell Therapy Market By Therapy
12.6.11.4 Rest of Latin America Stem Cell Therapy Market By End-Use
12.6.11.5 Rest of Latin America Stem Cell Therapy Market, By Technology
13. Company Profiles
13.1 Thermo Fisher Scientific, Inc.
13.1.1 Company Overview
13.1.2 Financial
13.1.3 Products/ Services Offered
13.1.4 The SNS View
13.2 Lonza
13.2.1 Company Overview
13.2.2 Financial
13.2.3 Products/ Services Offered
13.2.4 The SNS View
13.3 Merck KGaA
13.3.1 Company Overview
13.3.2 Financial
13.3.3 Products/ Services Offered
13.3.4 The SNS View
13.4 CellGenix GmbH
13.4.1 Company Overview
13.4.2 Financial
13.4.3 Products/ Services Offered
13.4.4 The SNS View
13.5 Takara Bio
13.5.1 Company Overview
13.5.2 Financial
13.5.3 Products/ Services Offered
13.5.4 The SNS View
13.6 Cellartis AB
13.6.1 Company Overview
13.6.2 Financial
13.6.3 Products/ Services Offered
13.6.4 The SNS View
13.7 AcceGen
13.7.1 Company Overview
13.7.2 Financial
13.7.3 Products/ Services Offered
13.7.4 The SNS View
13.8 Cell Applications, Inc.
13.8.1 Company Overview
13.8.2 Financial
13.8.3 Products/ Services Offered
13.8.4 The SNS View
13.9 ATCC
13.9.1 Company Overview
13.9.2 Financial
13.9.3 Products/ Services Offered
13.9.4 The SNS View
13.10 PromoCell GmbH
13.10.1 Company Overview
13.10.2 Financial
13.10.3 Products/ Services Offered
13.10.4 The SNS View
13.11 Bio-Techne
13.11.1 Company Overview
13.11.2 Financial
13.11.3 Products/ Services Offered
13.11.4 The SNS View
13.12 STEMCELL Technologies Inc.
13.12.1 Company Overview
13.12.2 Financial
13.12.3 Products/ Services Offered
13.12.4 The SNS View
14. Competitive Landscape
14.1 Competitive Benchmarking
14.2 Market Share Analysis
14.3 Recent Developments
14.3.1 Industry News
14.3.2 Company News
14.3.3 Mergers & Acquisitions
15. Use Case and Best Practices
16. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Product
Adult Stem Cells (ASCs)
Human Embryonic Stem Cells (HESCs)
Induced Pluripotent Stem Cells (iPSCs)
Very Small Embryonic Like Stem Cells
By Application
Neurological Disorders
Orthopaedic Treatments
Oncology Disorders
Injuries and Wounds
Cardiovascular Disorders
Others
By Therapy
Allogeneic
Autologic
Syngeneic
By End-Use
Pharmaceutical & Biotechnology Companies
Hospitals & Cell Banks
Academic & Research Institutes
By Technology
Cell Acquisition
Cell Production
Cryopreservation
Expansion and Sub-Culture
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
• With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
• Product Analysis
• Criss-Cross segment analysis (e.g. Product X Application)
• Product Matrix which gives a detailed comparison of product portfolio of each company
• Geographic Analysis
• Additional countries in any of the regions
• Company Information
• Detailed analysis and profiling of additional market players (Up to five)
The Digital Clinical Trials Market was valued at USD 8.70 billion in 2023 and is expected to reach at USD 13.86 billion in 2031 and grow at a CAGR of 6 % over the forecast period of 2024-2031.
The eClinical Solutions Market Size was valued at USD 8.33 billion in 2022 and is expected to reach USD 22.94 billion by 2030 and grow at a CAGR of 13.5% over the forecast period 2023-2030.
The Healthcare Supply Chain Management Market is expected to reach USD 10.14 billion by 2031, and Size was valued at USD 3 billion in 2023, and grow at a CAGR of 14.5 % over the forecast period 2024-2031.
The Functional Service Providers (FSP) Market Size was valued at USD 14.58 billion in 2022, and is expected to reach USD 26.98 billion by 2030, and grow at a CAGR of 8% over the forecast period 2023-2030.
The Biopharmaceutical CMO Market size was valued at USD 15.31 billion in 2023 and is expected to reach USD 50.19 billion by 2031 with a growing CAGR of 16% over the forecast period of 2024-2031.
The Bone Morphogenetic Protein Market size was estimated at USD 0.53 billion in 2023 and is expected to reach USD 0.72 billion by 2032 with a growing CAGR of 3.50% during the forecast period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
